UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 66

Sortiert nach

Secukinumab for the treatment of residual psoriasis: a case series

The Journal of dermatological treatment, 2018-11, Vol.29 (sup1), p.12-13

Malagoli, Piergiorgio

2018

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Ramadan Fasting on the Reduction of PASI Score, in Moderate-To-Severe Psoriatic Patients: A Real-Life Multicenter Study

Nutrients, 2019-01, Vol.11 (2), p.277

2019

Link zum Volltext

Verfügbarkeit prüfen

Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study

Acta dermato-venereologica, 2021-11, Vol.101 (11), p.adv00605-adv00605

2021

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Intermittent Fasting (Ramadan Fasting) on Psoriatic Arthritis Disease Activity, Enthesitis, and Dactylitis: A Multicentre Study

Nutrients, 2019-03, Vol.11 (3), p.601

2019

Link zum Volltext

Verfügbarkeit prüfen

The Safety and Impact of a Model of Intermittent, Time-Restricted Circadian Fasting ("Ramadan Fasting") on Hidradenitis Suppurativa: Insights from a Multicenter, Observational, Cross-Over, Pilot, Exploratory Study

Nutrients, 2019-08, Vol.11 (8), p.1781

2019

Link zum Volltext

Verfügbarkeit prüfen

Patients’ demographic and socioeconomic characteristics influence the therapeutic decision-making process in psoriasis

PloS one, 2020-08, Vol.15 (8), p.e0237267-e0237267

2020

Link zum Volltext

Verfügbarkeit prüfen

Antihistamines-refractory chronic pruritus in psoriatic patients undergoing biologics: aprepitant vs antihistamine double dosage, a real-world data

The Journal of dermatological treatment, 2022-05, Vol.33 (3), p.1554-1557

2022

Link zum Volltext

Verfügbarkeit prüfen

Successful use of tralokinumab for the treatment of atopic dermatitis on the genitals

The Journal of dermatological treatment, 2024-12, Vol.35 (1), p.2351489-2351489

2024

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience

The Journal of dermatological treatment, 2023-12, Vol.34 (1), p.2268764-2268764

2023

Link zum Volltext

Verfügbarkeit prüfen

Ixekizumab is effective in the long-term management in moderate-to-severe plaque psoriasis: results from an Italian retrospective cohort study (the LOTIXE study)

The Journal of dermatological treatment, 2023-12, Vol.34 (1), p.2246606-2246606

2023

Link zum Volltext

Verfügbarkeit prüfen

Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retrospective, real-world study

The Journal of dermatological treatment, 2020-07, Vol.31 (5), p.476-483

2020

Link zum Volltext

Verfügbarkeit prüfen

Secukinumab Loss of Efficacy Is Perfectly Counteracted by the Introduction of Combination Therapy (Rescue Therapy): Data from a Multicenter Real-Life Study in a Cohort of Italian Psoriatic Patients That Avoided Secukinumab Switching

Pharmaceuticals (Basel, Switzerland), 2022-01, Vol.15 (1), p.95

2022

Link zum Volltext

Verfügbarkeit prüfen

Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study - IL PSO (Italian landscape psoriasis)

The Journal of dermatological treatment, 2024-12, Vol.35 (1), p.2350760-2350760

2024

Link zum Volltext

Verfügbarkeit prüfen

A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal study

BMC health services research, 2021-09, Vol.21 (1), p.1-13, Article 924

2021

Link zum Volltext

Verfügbarkeit prüfen

Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus

Dermatology and therapy, 2024-04, Vol.14 (4), p.919-932

2024

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study—IL PSO (Italian landscape psoriasis)

Frontiers in medicine, 2023-08, Vol.10, p.1243843-1243843

2023

Link zum Volltext

Verfügbarkeit prüfen

Semaglutide therapy decreases epicardial fat inflammation and improves psoriasis severity in patients affected by abdominal obesity and type-2 diabetes

Endocrinology, diabetes & metabolism case reports, 2023-08, Vol.2023 (3), p.1-7

2023

Link zum Volltext

Verfügbarkeit prüfen

PACE study: real-life Psoriasis Area and Severity Index (PASI) 100 response with biological agents in moderate-severe psoriasis

The Journal of dermatological treatment, 2018-07, Vol.29 (5), p.481-486

2018

Link zum Volltext

Verfügbarkeit prüfen

Bimekizumab for the Treatment of Plaque Psoriasis with Involvement of Genitalia: A 16-Week Multicenter Real-World Experience - IL PSO (Italian Landscape Psoriasis)

Dermatology practical & conceptual, 2024-04, Vol.14 (2), p.e2024052

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(56)

Publikationsform

Artikel
(63)
Berichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Secukinumab for the treatment of residual psoriasis: a case series

The Impact of Ramadan Fasting on the Reduction of PASI Score, in Moderate-To-Severe Psoriatic Patients: A Real-Life Multicenter Study

Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study

The Impact of Intermittent Fasting (Ramadan Fasting) on Psoriatic Arthritis Disease Activity, Enthesitis, and Dactylitis: A Multicentre Study

The Safety and Impact of a Model of Intermittent, Time-Restricted Circadian Fasting ("Ramadan Fasting") on Hidradenitis Suppurativa: Insights from a Multicenter, Observational, Cross-Over, Pilot, Exploratory Study

Patients’ demographic and socioeconomic characteristics influence the therapeutic decision-making process in psoriasis

Antihistamines-refractory chronic pruritus in psoriatic patients undergoing biologics: aprepitant vs antihistamine double dosage, a real-world data

SARS-CoV-2 Infection Induces Psoriatic Arthritis Flares and Enthesis Resident Plasmacytoid Dendritic Cell Type-1 Interferon Inhibition by JAK Antagonism Offer Novel Spondyloarthritis Pathogenesis Insights

Successful use of tralokinumab for the treatment of atopic dermatitis on the genitals

Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience

Ixekizumab is effective in the long-term management in moderate-to-severe plaque psoriasis: results from an Italian retrospective cohort study (the LOTIXE study)

Drug survival of IL-12/23, IL-17 and IL-23 inhibitors for moderate-to-severe plaque psoriasis: a retrospective multicenter real-world experience on 5932 treatment courses - IL PSO (Italian landscape psoriasis)

Secukinumab demonstrates improvements in absolute and relative psoriasis area severity indices in moderate-to-severe plaque psoriasis: results from a European, multicentric, retrospective, real-world study

Secukinumab Loss of Efficacy Is Perfectly Counteracted by the Introduction of Combination Therapy (Rescue Therapy): Data from a Multicenter Real-Life Study in a Cohort of Italian Psoriatic Patients That Avoided Secukinumab Switching

Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study - IL PSO (Italian landscape psoriasis)

A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal study

Management of Patients Affected by Moderate-to-Severe Atopic Dermatitis with JAK Inhibitors in Real-World Clinical Practice: An Italian Delphi Consensus

Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study—IL PSO (Italian landscape psoriasis)

Semaglutide therapy decreases epicardial fat inflammation and improves psoriasis severity in patients affected by abdominal obesity and type-2 diabetes

PACE study: real-life Psoriasis Area and Severity Index (PASI) 100 response with biological agents in moderate-severe psoriasis

Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study—IL PSO (Italian Landscape Psoriasis)

Brodalumab for the treatment of plaque psoriasis in a real-life setting: a 3 years multicenter retrospective study-IL PSO (Italian landscape psoriasis)

Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study-IL PSO (ITALIAN LANDSCAPE PSORIASIS)

Bimekizumab for the Treatment of Plaque Psoriasis with Involvement of Genitalia: A 16-Week Multicenter Real-World Experience - IL PSO (Italian Landscape Psoriasis)

Achievement and maintenance of therapeutic response to brodalumab in patients with moderate‐to‐severe plaque psoriasis: An Italian, observational, retrospective and prospective study (BRIGHT study)

Suchergebnisse filtern